When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

In this week’s Kern Cares, Dr. Hashimoto from BFMG joined host Kait Hill to unpack one of today’s most talked-about health ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...

Pediatric dermatologists must play an active role in treating obesity in children, according to a presenter at the Society ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade.

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

Texas already has the highest uninsured rate in the country, and higher marketplace costs could push more people to forego coverage. "Most enrollees are going to be facing a double whammy of both ...